换一批Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial.
第一作者：
Xinxue,Liu
第一单位：
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. Electronic address: xinxue.liu@paediatrics.ox.ac.uk.
作者：
Xinxue,Liu [1]
;
Alasdair P S,Munro [2]
;
Annie,Wright [3]
;
Shuo,Feng [4]
;
Leila,Janani [3]
;
Parvinder K,Aley [5]
;
Gavin,Babbage [2]
;
Jonathan,Baker [6]
;
David,Baxter [7]
;
Tanveer,Bawa [8]
;
Marcin,Bula [9]
;
Katrina,Cathie [6]
;
Krishna,Chatterjee [10]
;
Kate,Dodd [9]
;
Yvanne,Enever [11]
;
Lauren,Fox [12]
;
Ehsaan,Qureshi [13]
;
Anna L,Goodman [14]
;
Christopher A,Green [13]
;
John,Haughney [15]
;
Alexander,Hicks [12]
;
Christine E,Jones [6]
;
Nasir,Kanji [4]
;
Agatha A,van der Klaauw [16]
;
Vincenzo,Libri [17]
;
Martin J,Llewelyn [18]
;
Rebecca,Mansfield [19]
;
Mina,Maallah [20]
;
Alastair C,McGregor [20]
;
Angela M,Minassian [21]
;
Patrick,Moore [22]
;
Mehmood,Mughal [7]
;
Yama F,Mujadidi [23]
;
Hanane Trari,Belhadef [23]
;
Kyra,Holliday [24]
;
Orod,Osanlou [25]
;
Rostam,Osanlou [26]
;
Daniel R,Owens [6]
;
Mihaela,Pacurar [6]
;
Adrian,Palfreeman [27]
;
Daniel,Pan [28]
;
Tommy,Rampling [17]
;
Karen,Regan [4]
;
Stephen,Saich [2]
;
Dinesh,Saralaya [29]
;
Sunil,Sharma [18]
;
Ray,Sheridan [30]
;
Matthew,Stokes [2]
;
Emma C,Thomson [31]
;
Shirley,Todd [30]
;
Chris,Twelves [24]
;
Robert C,Read [6]
;
Sue,Charlton [32]
;
Bassam,Hallis [32]
;
Mary,Ramsay [33]
;
Nick,Andrews [33]
;
Teresa,Lambe [4]
;
Jonathan S,Nguyen-Van-Tam [34]
;
Victoria,Cornelius [3]
;
Matthew D,Snape [5]
;
Saul N,Faust [35]
;
COV-BOOST study group
作者单位：
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. Electronic address: xinxue.liu@paediatrics.ox.ac.uk.
[1]
NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
[2]
Imperial Clinical Trials Unit, Imperial College London, London, UK.
[3]
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
[4]
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
[5]
NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK.
[6]
Stockport NHS Foundation Trust, Stockport, UK.
[7]
Department of Infection, Guy's and St Thomas' NHS Foundation Trust, London, UK.
[8]
NIHR Liverpool Clinical Research Facility, Liverpool, UK.
[9]
NIHR Cambridge Clinical Research Facility, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
[10]
PHARMExcel, Welwyn Garden City, Hertfordshire, UK.
[11]
Portsmouth Hospitals University NHS Trust, Portsmouth, UK.
[12]
NIHR/Wellcome Clinical Research Facility, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
[13]
Department of Infection, Guy's and St Thomas' NHS Foundation Trust, London, UK; MRC Clinical Trials Unit, University College London, London, UK.
[14]
Queen Elizabeth University Hospital, NHS Greater Glasgow & Clyde, Glasgow, UK.
[15]
Wellcome-MRC Institute of Metabolic Science, Department of Clinical Biochemistry, University of Cambridge, Cambridge, UK.
[16]
NIHR UCLH Clinical Research Facility and NIHR UCLH Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK.
[17]
University Hospitals Sussex NHS Foundation Trust, Brighton, UK.
[18]
Dorset Research Hub, Bournemouth, UK.
[19]
Department of Infectious Diseases and Tropical Medicine, London Northwest University Healthcare, London, UK.
[20]
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
[21]
The Adam Practice, Poole, UK.
[22]
NIHR Oxford Biomedical Research Centre, Oxford, UK.
[23]
NIHR Leeds Clinical Research Facility, Leeds Teaching Hospitals Trust and University of Leeds, Leeds, UK.
[24]
Public Health Wales, Betsi Cadwaladr University Health Board, Bangor University, Bangor, UK.
[25]
University of Liverpool, Liverpool, UK.
[26]
University Hospitals of Leicester NHS Trust, University of Leicester, Leicester, UK.
[27]
University Hospitals of Leicester NHS Trust, University of Leicester, Leicester, UK; Department of Respiratory Sciences, University of Leicester, Leicester, UK.
[28]
Bradford Institute for Health Research and Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK.
[29]
Royal Devon and Exeter Hospital NHS Foundation Trust, Exeter, UK.
[30]
Queen Elizabeth University Hospital, NHS Greater Glasgow & Clyde, Glasgow, UK; MRC University of Glasgow Centre for Virus Research, Glasgow, UK.
[31]
UK Health Security Agency, Porton Down, UK.
[32]
UK Health Security Agency, Colindale, London, UK.
[33]
Lifespan and Population Health Unit, University of Nottingham School of Medicine, UK.
[34]
NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK. Electronic address: s.faust@soton.ac.uk.
[35]
医学主题词
女(雌)性(Female);人类(Humans);老年人(Aged);男(雄)性(Male);病毒疫苗(Viral Vaccines);免疫(Immunity);免疫球蛋白G(Immunoglobulin G);抗体, 病毒(Antibodies, Viral);接种(Vaccination)
DOI
10.1016/j.jinf.2023.04.012
PMID
37085049
发布时间
2025-05-30
- 浏览1
The Journal of infection
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
